RBC Comments on Vertex (VRTX) Following Orkambi Briefing Docs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- US stock futures rise on tech rebound before Nvidia, inflation tests
- Oil hits one-week low as investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
UPDATE: Vertex Pharma's (VRTX) Orkamibi Recommended for Approval by FDA Panel
May 12, 2015 3:42 PM EDT(Updated - May 12, 2015 3:46 PM EDT)
Vertex Pharma (NASDAQ: VRTX) Orkamibi Recommended for Approval by FDA Panel. According to Bloomberg, the panel vote was 12-1.
Previously, the FDA panel said Orkambi is safe to treat cystic fibrosis and that it couldn't determine if Lumacaftor contributes positively to Orkambi combo.
... MoreVertex Pharma (VRTX) Shares Halted Ahead of FDA Advisory Committee Meeting
May 12, 2015 7:31 AM EDTVertex Pharma (NASDAQ: VRTX) shares were halted for news ahead of an FDA advisory committee meeting on Orkambi.
... MoreVertex (VRTX) Orkambi Briefing Docs 'Positive Overall', Baird Says
May 8, 2015 12:29 PM EDTBaird analyst Brian Skorney weighed in on Outperform-rated Vertex (NASDAQ: VRTX) after the FDA briefing docs on Orkambi. While not benign he said they look positive overall.
"The FDA review of the lumacaftor/ivacaftor combo didn't yield any smoking gun and generally... More
Vertex Pharma (VRTX) on Watch After FDA Posts Briefing Docs for Orkambi to Treat CF
May 8, 2015 8:03 AM EDTThe FDA posted briefing docs related to Vertex Pharma's (NASDAQ: VRTX) lumacaftor/ivacaftor (Orkambi) combination oral tablets for the treatment of cystic fibrosis.
... More